L-Z Wang Selected Research

NU2058

1/2010

Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L-Z Wang Research Topics

Disease

4	Neoplasms (Cancer) 08/2014 - 01/2010
3	Breast Neoplasms (Breast Cancer) 07/2011 - 01/2010
1	Myocardial Infarction 12/2020
1	Body Weight (Weight, Body) 08/2014
1	Necrosis 08/2014
1	Ovarian Neoplasms (Ovarian Cancer) 07/2011
1	Ataxia Telangiectasia (Louis Bar Syndrome) 07/2011
1	Febrile Neutropenia 11/2010
1	Neutropenia 11/2010

Drug/Important Bio-Agent (IBA)

1	salicylhydroxamic acid (SHAM)IBA 12/2020
1	Saline SolutionIBA 12/2020
1	RNA (Ribonucleic Acid)IBA 12/2020
1	Sirtuin 1IBA 12/2020
1	Proteins (Proteins, Gene)FDA Link 08/2014
1	Caspase 3 (Caspase-3)IBA 08/2014
1	crocinIBA 08/2014
1	Mitogen-Activated Protein KinasesIBA 08/2014
1	Phosphotransferases (Kinase)IBA 07/2011
1	4- cyclohexylmethoxy- 5- nitrosopyrimidine- 2,6- diamineIBA 07/2011
1	Ketoconazole (Nizoral)FDA LinkGeneric 11/2010
1	Docetaxel (Taxotere)FDA Link 11/2010
1	NU6102IBA 01/2010
1	Small Interfering RNA (siRNA)IBA 01/2010
1	CyclinsIBA 01/2010
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2010
1	NU2058IBA 01/2010
1	Estrogens (Estrogen)FDA Link 01/2010
1	Cyclin-Dependent Kinase 2IBA 01/2010
1	purineIBA 01/2010

Therapy/Procedure

2	Therapeutics 07/2011 - 01/2010
1	Thoracotomy 12/2020
1	Intraperitoneal Injections 08/2014